Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease

被引：29

作者：

Bannai, Ei ^{[1
]}

Yamashita, Hiroyuki ^{[1
]}

Kaneko, Shunta ^{[1
]}

Ueda, Yo ^{[1
]}

Ozaki, Takashi ^{[1
]}

Tsuchiya, Haruka ^{[1
]}

Takahashi, Yuko ^{[1
]}

Kaneko, Hiroshi ^{[1
]}

Kano, Toshikazu ^{[1
]}

Mimori, Akio ^{[1
]}

机构：

[1] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan

来源：

MODERN RHEUMATOLOGY | 2016年 / 26卷 / 02期

关键词：

Adult-onset Still's disease; Tocilizumab; Macrophage activation syndrome; MACROPHAGE ACTIVATION SYNDROME; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; RECEPTOR ANTIBODY; IL-6; RECEPTOR; EFFICACY; INTERLEUKIN-6; AGENTS; TRIAL;

D O I：

10.3109/14397595.2014.899178

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To evaluate the effects of tocilizumab (TCZ) on adult-onset Still's disease (AOSD), we reviewed medical records of seven patients with refractory AOSD treated with TCZ at our institution. TCZ therapy might allow rapid corticosteroid tapering and help maintain remission status, that is, resolution of clinical symptoms and normalization of biomarkers such as CRP and ferritin. Patients, however, should be monitored for the development of macrophage activation syndrome when TCZ is administered for active AOSD.

引用

页码：297 / 301

页数：5

共 50 条

[41] Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
Hubert de Boysson
Jérome Février
Amélie Nicolle
Christophe Auzary
Loïk Geffray
Clinical Rheumatology, 2013, 32 : 141 - 147
[42] Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
de Boysson, Hubert
Fevrier, Jerome
Nicolle, Amelie
Auzary, Christophe
Geffray, Loik
CLINICAL RHEUMATOLOGY, 2013, 32 (01) : 141 - 147
[43] Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
Sumida, Keiichi
Ubara, Yoshifumi
Hoshino, Junichi
Suwabe, Tatsuya
Hiramatsu, Rikako
Hasegawa, Eiko
Hayami, Noriko
Yamanouchi, Masayuki
Sawa, Naoki
Takemoto, Fumi
Takaichi, Kenmei
CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1191 - 1194
[44] Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab
Wawrzycki, Bartlomiej
Krasowska, Dorota
Pietrzak, Aldona
Wielosz, Ewa
Majdan, Maria
Lotti, Torello
DERMATOLOGIC THERAPY, 2019, 32 (05)
[45] Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
Keiichi Sumida
Yoshifumi Ubara
Junichi Hoshino
Tatsuya Suwabe
Rikako Hiramatsu
Eiko Hasegawa
Noriko Hayami
Masayuki Yamanouchi
Naoki Sawa
Fumi Takemoto
Kenmei Takaichi
Clinical Rheumatology, 2010, 29 : 1191 - 1194
[46] A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still's Disease (vol 7, 13477, 2017)
Li, Ting
Gu, Liyang
Wang, Xiaodong
Guo, Li
Shi, Hui
Yang, Chengde
Chen, Sheng
SCIENTIFIC REPORTS, 2018, 8
[47] Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
Ryota Sakai
Hayato Nagasawa
Eiko Nishi
Ayumi Okuyama
Hirofumi Takei
Takahiko Kurasawa
Tsuneo Kondo
Koji Nishimura
Yuichiro Shirai
Tatsuya Ito
Hideto Kameda
Tsutomu Takeuchi
Koichi Amano
Clinical Rheumatology, 2012, 31 : 569 - 574
[48] Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review
Sakai, Ryota
Nagasawa, Hayato
Nishi, Eiko
Okuyama, Ayumi
Takei, Hirofumi
Kurasawa, Takahiko
Kondo, Tsuneo
Nishimura, Koji
Shirai, Yuichiro
Ito, Tatsuya
Kameda, Hideto
Takeuchi, Tsutomu
Amano, Koichi
CLINICAL RHEUMATOLOGY, 2012, 31 (03) : 569 - 574
[49] Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases
Song, S. T.
Kim, J. J.
Lee, S.
Kim, H. A.
Lee, E. Y.
Shin, K. C.
Lee, J. H.
Lee, K. H.
Choi, S. T.
Cha, H. S.
Yoo, D. H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S64 - S71
[50] Tocilizumab in Refractory Adult Still's Disease
Puechal, Xavier
de Bandt, Michel
Berthelot, Jean-Marie
Breban, Maxime
Dubost, Jean-Jacques
Fain, Olivier
Kahn, Jean-Emmanuel
Lequen, Laurence
Longy-Boursier, Maite
Perdriger, Aleth
Schaeverbeke, Thierry
Toussirot, Eric
Sibilia, Jean
ARTHRITIS CARE & RESEARCH, 2011, 63 (01) : 155 - 159

← 1 2 3 4 5 →